1 of 1
HOUSE DOCKET, NO. 4409 FILED ON: 6/20/2023
HOUSE . . . . . . . . . . . . . . . No. 4068
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
F. Jay Barrows, (BY REQUEST)
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to diabetic financial protection, assistance, and additional healthcare coverage.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Julie Mejia274 East Main Street, Suite 3305,
Norton, MA 02766
6/20/2023 1 of 2
HOUSE DOCKET, NO. 4409 FILED ON: 6/20/2023
HOUSE . . . . . . . . . . . . . . . No. 4068
By Representative Barrows of Mansfield (by request), a petition (subject to Joint Rule 12) of
Julie Mejia relative to health insurance coverage for diabetic products. Financial Services.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act relative to diabetic financial protection, assistance, and additional healthcare coverage.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Chapter 175 of the General Laws, as appearing in the 2020 Official Edition,
2is hereby amended by inserting the following section:-
3 Section 47UU. (a) For the purposes of this section, the following terms shall have the
4following meanings unless the context clearly requires otherwise:
5 “Diabetic products”, prescription medications, diabetic testing supplies, and medical
6equipment necessary for treating diabetes.
7 “Smart InPens”, are all reusable insulin pens for the treatment of both Type 1 and Type 2
8diabetes, which may include additional features, such as Bluetooth technology.
9 (b) Health insurance providers shall ensure that diabetic products adhere to the following
10price standards: (1) The general price of diabetic testing strips shall not exceed $10 per monthly
11supply of test strips. (2) The general price of diabetic lancets shall not exceed $10 per monthly
12supply of lancets. (3) The general price of diabetic pen needles and syringes shall not exceed $10 2 of 2
13per monthly supply of pen needles and syringes. (4) The general price of insulin pumps and
14delivery systems shall not exceed $100 per pump. (5) The general price of a monthly supply of
15infusion sets for delivery systems shall not exceed $10 per month. (6) The general price of
16insulin cartridges for delivery devices shall not exceed $10 per month. (7) The general price of
17CGM transmitters shall not exceed $20 per transmitter. (8) The general price of a monthly supply
18of CGM sensors shall not exceed $20 per monthly supply. (9) The general price of insulin pens
19or vials shall not exceed $15 per month for vials or pens necessary for the treatment of patients.
20(10) The general price of blood glucose meters and monitoring systems shall not exceed $20 per
21system. (11) The general price of oral diabetes medication shall not exceed $10 per monthly
22supply of medication. (12) The general price of diabetic stem cell therapies shall not exceed $100
23per session. (13) The general price of Smart InPens shall not exceed $20 per InPen. (14) If a
24patient requires three or more discrete diabetic medications, testing supplies, or equipment, the
25patient shall not be required to pay more than $100 a month for costs related to diabetes
26treatment.
27 (c) Nothing in this section shall be construed to limit the requirements for MassHealth to
28provide additional coverage for diabetic medication and healthcare-related products.
29 SECTION 2. Section 1 of this act shall take effect on January 1, 2024.